Header Logo

Connection

HUSSEIN TAWBI to Patient Safety

Back to Details
This is a "connection" page, showing publications HUSSEIN TAWBI has written about Patient Safety.
HUSSEIN TAWBI
Connection Strength
0.102
Patient Safety
  1. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 11; 18(11):1493-1501.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.